Erratum: Brainstem Impacts and Outcome Correlations of QSM at 7T in COVID-19

Overview

This erratum addresses corrections to the acknowledgements and funding sections of the original article evaluating brainstem effects and outcome associations using quantitative susceptibility mapping (QSM) at 7 Tesla in COVID-19 patients. The corrections clarify contributions and funding sources supporting the research.

Background

Quantitative susceptibility mapping (QSM) at ultra-high field strength (7 Tesla) is a neuroimaging technique used to assess brain tissue magnetic properties, potentially revealing pathological changes. The original study investigated brainstem impacts and clinical outcome correlations in COVID-19 patients using QSM. Accurate reporting of acknowledgements and funding is essential for transparency and recognition of contributions in clinical research.

Data Highlights

No numerical data are presented in this erratum; it focuses on corrections to text sections regarding acknowledgements and funding.

Key Findings

• The acknowledgements section was corrected to include thanks to NIHR BioResource volunteers, NIHR BioResource centres, NHS Trusts and staff, and additional organizations involved in the study.
• The original acknowledgements omitted several key contributors and supporting organizations.
• The funding section was updated to include support from the NIHR BioResource, which was previously omitted.
• The corrected funding statement clarifies the specific grants and institutions supporting the work.
• The authors emphasize that the views expressed are those of the authors and not necessarily those of the NHS, NIHR, or Department of Health and Social Care.

Clinical Implications

While this erratum does not alter the clinical findings of the original study, it highlights the importance of accurate and comprehensive reporting of funding and acknowledgements in clinical research. Proper attribution ensures transparency and supports the integrity of research collaborations, which is critical in advancing understanding of COVID-19 neurological impacts.

Conclusion

The corrections to acknowledgements and funding enhance the transparency and completeness of the original publication on brainstem effects in COVID-19 assessed by QSM at 7T. These amendments do not affect the study’s scientific conclusions.

References

1. Rua et al. 2024 -- Quantitative susceptibility mapping at 7 T in COVID-19: brainstem effects and outcome associations